On a national level, over the past 19 years, our ability to identify and to treat patients with AAA has not improved. Advances in technology and critical care have not affected outcome. Regionalization of care, screening of high-risk populations, and endovascular repair are strategies that might allow further improvement in the outcome of patients with aneurysmal disease.

Atherosclerosis is an inflammatory process characterized by proliferation and dedifferentiation of vascular smooth muscle cells (VSMC). Cav1.2 calcium channels may have a role in atherosclerosis because they are essential for Ca 2؉ -signal transduction in VSMC. The pore-forming Cav1.2␣1 subunit of the channel is subject to alternative splicing. Here, we investigated whether the Cav1.2␣1 splice variants are affected by atherosclerosis. VSMC were isolated by laser-capture microdissection from frozen sections of adjacent regions of arteries affected and not affected by atherosclerosis. In VSMC from nonatherosclerotic regions, RT-PCR analysis revealed an extended repertoire of Cav1.2␣1 transcripts characterized by the presence of exons 21 and 41A. In VSMC affected by atherosclerosis, expression of the Cav1.2␣1 transcript was reduced and the Cav1.2␣1 splice variants were replaced with the unique exon-22 isoform lacking exon 41A. Molecular remodeling of the Cav1.2␣1 subunits associated with atherosclerosis caused changes in electrophysiological properties of the channels, including the kinetics and voltage-dependence of inactivation, recovery from inactivation, and rundown of the Ca 2؉ current. Consistent with the pathophysiological state of VSMC in atherosclerosis, cell culture data pointed to a potentially important association of the exon-22 isoform of Cav1.2␣1 with proliferation of VSMC. Our findings are consistent with a hypothesis that localized changes in cytokine expression generated by inflammation in atherosclerosis affect alternative splicing of the Cav1.2␣1 gene in the human artery that causes molecular and electrophysiological remodeling of Cav1.2 calcium channels and possibly affects VSMC proliferation.alternative splicing ͉ cell proliferation ͉ vascular smooth muscle cells

No abstract